New DNA Barcode Method Shows How Gene Therapy Fails Inside Cells

A new DNA barcode tool helps scientists see how gene therapy works inside cells. This is important for making new medicines that can treat sickness better.
By Newsroom | Biotechnology, Health |

A new DNA barcoding technique has emerged, offering a way to track the fate of nanoparticles designed to deliver gene therapies inside living organisms. This method promises to clarify why many of these therapeutic delivery systems fail to reach their intended targets within cells, ultimately paving the way for more effective treatments.

The core challenge lies in how cells handle foreign material. Upon entering a cell, gene therapy carriers are often rerouted to lysosomes, the cell's internal recycling and waste disposal units. Here, the valuable therapeutic genetic material can be degraded before it has a chance to perform its intended function. For gene therapies to work, these carriers must evade this cellular 'trash system' and arrive at the specific cellular locations where they can be active.

This new assay, developed by researchers at Oregon State University and collaborators, allows scientists to directly measure in vivo how much genetic cargo escapes cellular degradation and how much is destroyed. This capability represents a significant advancement, enabling, for the first time, rapid quantification of nanoparticle performance within living systems. The findings from these measurements have already guided the design of improved lipid nanoparticles. These next-generation carriers incorporate enhanced 'ionizable lipids,' demonstrating the potential for gene editing at substantially lower doses compared to existing approaches.

Read More: New Microbe Eats Methanol Faster for Cheaper Bioplastics in South Korea

The research, detailed in a publication within Nature Biotechnology, underscores the significance of Gaurav Sahay's work in drug delivery science. Jozić, working under Sahay's direction, spearheaded the practical application of this barcoding method. The study's collaborative nature is highlighted by contributions from institutions across the globe, including Oregon Health & Science University, Tennessee Technological University, Yeungnam University in South Korea, and the University of Brest in France.

Read More: UK Universities Admit Zero-Tolerance Policy Stops Students Asking for Help

Looking ahead, the insights gained from mapping these intracellular pathways could extend beyond current gene therapies. The technique holds promise for optimizing the delivery of a variety of therapeutic payloads, such as mRNA vaccines, small interfering RNAs (siRNA), and CRISPR-based gene editing tools. This development positions Oregon State University as a notable entity in the fields of drug delivery and biotechnological innovation, with the potential to unlock higher efficacies in gene delivery by strategically navigating cellular defense mechanisms.

Frequently Asked Questions

Q: What is the new DNA barcoding method?
It is a new way for scientists to track tiny particles used in gene therapy as they move inside living things. This helps them understand why these particles often fail to reach their target.
Q: Why do gene therapy carriers often fail inside cells?
Gene therapy carriers are often sent to the cell's 'trash system' called lysosomes. Here, the important genetic material can be destroyed before it can work.
Q: How does this new method help make gene therapy better?
The DNA barcode method lets scientists measure how much genetic material escapes being destroyed inside cells. This helps them design better nanoparticles, like those with new 'ionizable lipids', which can work at lower doses.
Q: What other treatments could this new method help?
This technique could help improve other treatments like mRNA vaccines, siRNA, and CRISPR gene editing tools by helping them get past the cell's defenses.
Q: Where did the researchers develop this new method?
Researchers at Oregon State University and other universities around the world, including in South Korea and France, worked on this new DNA barcoding method.